为应对 SARS-CoV-2 变异株对抗体疗法的挑战，研究人员开发 NTD-RBD 双特异性抗体，其体外中和效果良好且有体内预防潜力。他们的研究成果发表在《Science Translational Medicine》上，为抗击新冠疫情带来了新的希望。

These NTD-RBD bsAbs may form the basis for a new generation of anti-COVID-19 vaccines and antibody-based therapeutics against the disease. Study: Bispecific antibodies with broad neutralization ...